Literature DB >> 12358930

Induction of the CD163-dependent haemoglobin uptake by macrophages as a novel anti-inflammatory action of glucocorticoids.

Dominik J Schaer1, Felicitas S Boretti, Gabriele Schoedon, Andreas Schaffner.   

Abstract

Highly efficient systems remove toxic and pro-inflammatory haemoglobin (Hb) from the circulation and local sites of tissue damage. Macrophages are major Hb-clearing cells; CD163 was recently recognized as the specific haemoglobin-haptoglobin scavenger receptor (HSR). We show that dexamethasone strongly induced the specific uptake of haemoglobin-haptoglobin complexes, CD163 mRNA transcription (13-fold) and cell surface expression (10-fold) by human macrophages. In contrast, the TH2-cytokine interleukin 4 (IL-4) completely suppressed functional CD163 expression. The range of functional receptor modulation reached a factor of 100 after 4 h of macrophage-ligand interaction. Based on these results, we propose the augmentation of Hb clearance as a novel anti-inflammatory action of glucocorticoids.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12358930     DOI: 10.1046/j.1365-2141.2002.03790.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  31 in total

1.  Variation in inflammation as a correlate of range expansion in Kenyan house sparrows.

Authors:  Lynn B Martin; Jennifer L Alam; Titus Imboma; Andrea L Liebl
Journal:  Oecologia       Date:  2010-05-15       Impact factor: 3.225

2.  Modulation of macrophage phenotype via phagocytosis of drug-loaded microparticles.

Authors:  Kathryn L Wofford; D Kacy Cullen; Kara L Spiller
Journal:  J Biomed Mater Res A       Date:  2019-02-11       Impact factor: 4.396

3.  α(1)-Acid glycoprotein up-regulates CD163 via TLR4/CD14 protein pathway: possible protection against hemolysis-induced oxidative stress.

Authors:  Hisakazu Komori; Hiroshi Watanabe; Tsuyoshi Shuto; Azusa Kodama; Hitoshi Maeda; Kenji Watanabe; Hirofumi Kai; Masaki Otagiri; Toru Maruyama
Journal:  J Biol Chem       Date:  2012-07-17       Impact factor: 5.157

4.  The role of tumor necrosis factor-like weak inducer of apoptosis in atherosclerosis via its two different receptors.

Authors:  Hengdao Liu; Dan Lin; Hong Xiang; Wei Chen; Shaoli Zhao; Hui Peng; Jie Yang; Pan Chen; Shuhua Chen; Hongwei Lu
Journal:  Exp Ther Med       Date:  2017-06-14       Impact factor: 2.447

5.  Sustained IL-4 exposure leads to a novel pathway for hemophagocytosis, inflammation, and tissue macrophage accumulation.

Authors:  Joshua D Milner; Tatyana Orekov; Jerrold M Ward; Lily Cheng; Fernando Torres-Velez; Ilkka Junttila; Guangping Sun; Mark Buller; Suzanne C Morris; Fred D Finkelman; William E Paul
Journal:  Blood       Date:  2010-06-22       Impact factor: 22.113

6.  Glucocorticoids enhance CD163 expression in placental Hofbauer cells.

Authors:  Zhonghua Tang; Tracy Niven-Fairchild; Serkalem Tadesse; Errol R Norwitz; Catalin S Buhimschi; Irina A Buhimschi; Seth Guller
Journal:  Endocrinology       Date:  2012-11-09       Impact factor: 4.736

7.  Coronary intraplaque hemorrhage evokes a novel atheroprotective macrophage phenotype.

Authors:  Joseph J Boyle; Heather A Harrington; Emma Piper; Kay Elderfield; Jaroslav Stark; Robert C Landis; Dorian O Haskard
Journal:  Am J Pathol       Date:  2009-03       Impact factor: 4.307

8.  Shifts in macrophage phenotypes and macrophage competition for arginine metabolism affect the severity of muscle pathology in muscular dystrophy.

Authors:  S Armando Villalta; Hal X Nguyen; Bo Deng; Tomomi Gotoh; James G Tidball
Journal:  Hum Mol Genet       Date:  2008-11-07       Impact factor: 6.150

Review 9.  Recent advances in understanding haemochromatosis: a transition state.

Authors:  K J H Robson; A T Merryweather-Clarke; E Cadet; V Viprakasit; M G Zaahl; J J Pointon; D J Weatherall; J Rochette
Journal:  J Med Genet       Date:  2004-10       Impact factor: 6.318

Review 10.  Heterogeneity of microglial activation in the innate immune response in the brain.

Authors:  Carol A Colton
Journal:  J Neuroimmune Pharmacol       Date:  2009-08-05       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.